Last update 01 Nov 2024
Intech Biopharm Ltd.

Intech Biopharm Ltd.

Public Company|
2010|
Taiwan Province, China
|
50-100
| ROCO: 6461|
www.intechbiopharm.com

Overview

Tags

Respiratory Diseases
Immune System Diseases
Infectious Diseases
Small molecule drug
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases4
Infectious Diseases3
Hemic and Lymphatic Diseases1
Top 5 Drug TypeCount
Small molecule drug4
Chemical drugs1
Top 5 TargetCount
β2-adrenergic receptor(Beta-2 adrenergic receptor)1
GR x cPLA2α x β2-adrenergic receptor1
GR(Glucocorticoid receptor)1
M3 receptor(Muscarinic acetylcholine receptor M3)1

Related

7
Drugs associated with Intech Biopharm Ltd.
Budesonide/Formoterol Fumarate Dihydrate
Target
GR x β2-adrenergic receptor
Mechanism
GR agonists [+1]
Active Org.
Teva Pharmaceuticals Europe BV [+8]
Originator Org.
AstraZeneca PLCAstraZeneca PLC
Active Indication
Mild asthma [+2]
Inactive Indication
airway disease [+8]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date17 Nov 2004
Tiotropium Bromide
Target
M3 receptor
Mechanism
M3 receptor antagonists
Active Org.
Boehringer Ingelheim GmbHBoehringer Ingelheim GmbH [+8]
Originator Org.
C.H. Boehringer Sohn AG & Co. KG
Active Indication
Asthma [+4]
Inactive Indication
Acute respiratory disease [+6]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date30 Jan 2004
Fluticasone propionate/Salmeterol xinafoate
Target
GR x cPLA2α x β2-adrenergic receptor
Mechanism
GR agonists [+2]
Active Org.
Jiangsu Simcere Pharmaceutical Co., Ltd.Jiangsu Simcere Pharmaceutical Co., Ltd. [+10]
Originator Org.
GSK PlcGSK Plc
Active Indication
Airway Obstruction [+2]
Inactive Indication
Bronchitis, Chronic [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date24 Aug 2000
13
Clinical Trials associated with Intech Biopharm Ltd.
CTRI/2024/03/064870 / RecruitingNot Applicable
A Randomized, Single dose, Double blind, Double dummy, Placebo and Active Controlled, Crossover Design Study Using Bronchoprovocation to Evaluate the Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients with Stable Mild Asthma. - NIL
NCT04912596 / RecruitingNot Applicable
A Randomized, Single-dose, Double-blind, Double-dummy, Placebo and Active Controlled, Crossover Design Study Using Bronchoprovocation to Evaluate the Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma
NCT05300087 / CompletedNot Applicable
A Randomized, Single-dose, Open-label, Two-way Crossover Pivotal Study to Assess the Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108mcg Per Actuation (MDI, eq. to Albuterol 90mcg/Puff) and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90mcg Per Actuation (MDI, eq. to Albuterol 90mcg/Puff) in Healthy Volunteers Under Fasting Conditions
100 Clinical Results associated with Intech Biopharm Ltd.
Login to view more data
0 Patents (Medical) associated with Intech Biopharm Ltd.
Login to view more data
100 Deals associated with Intech Biopharm Ltd.
Login to view more data
100 Translational Medicine associated with Intech Biopharm Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
Phase 1 Clinical
NDA/BLA
1
1
Approved
Other
2
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free